Bildkälla: Stockfoto

Annexin Pharmaceuticals: Phase II Study approved to Start - Redeye

Redeye is encouraged by today’s news that Annexin’s phase II trial is approved to start in the US as well as by the overall positive momentum in the company. We give a short comment.

Redeye is encouraged by today’s news that Annexin’s phase II trial is approved to start in the US as well as by the overall positive momentum in the company. We give a short comment.
Börsvärldens nyhetsbrev
ANNONSER